Active Ingredient: IMATINIB MESYLATE
Proprietary Name: IMATINIB MESYLATE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: EQ 100MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A207495
Product Number: 001
Approval Date: Feb 8, 2019
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS OF NEW YORK LLC
Marketing Status:
Discontinued
Patent and Exclusivity Information